Mexico - Delayed Quote MXN

Atossa Therapeutics, Inc. (ATOS.MX)

Compare
14.70
-1.30
(-8.13%)
At close: 1:12:44 PM CST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
29,489
--
27,691
20,521
14,607
Operating Income
-29,489
--
-27,691
-20,521
-14,607
Net Non Operating Interest Income Expense
4,449
--
877
6
-938.79
Other Income Expense
-1,871
--
-146
-91
-3,221
Pretax Income
-26,911
--
-26,960
-20,606
-17,828
Net Income Common Stockholders
-26,911
--
-26,960
-20,606
-22,331
Diluted NI Available to Com Stockholders
-26,911
--
-26,960
-20,606
-22,331
Basic EPS
-0.21
-0.24
-0.21
-0.18
-1.97
Diluted EPS
-0.21
-0.24
-0.21
-0.18
-1.97
Basic Average Shares
125,530.48
126,081.60
126,624
116,950
11,309
Diluted Average Shares
125,530.48
126,081.60
126,624
116,950
11,309
Total Operating Income as Reported
-29,489
--
-27,691
-20,521
-14,607
Total Expenses
29,489
--
27,691
20,521
14,607
Net Income from Continuing & Discontinued Operation
-26,911
--
-26,960
-20,606
-17,828
Normalized Income
-25,201
--
-26,960
-20,606
-14,556
Interest Income
4,449
--
877
6
--
Net Interest Income
4,449
--
877
6
-938.79
EBIT
-29,489
--
-27,691
-20,521
-14,607
EBITDA
-29,462
--
-27,683
-20,498
-14,560
Reconciled Depreciation
27
--
8
23
47
Net Income from Continuing Operation Net Minority Interest
-26,911
--
-26,960
-20,606
-17,828
Total Unusual Items Excluding Goodwill
-1,710
--
--
--
-3,272
Total Unusual Items
-1,710
--
--
--
-3,272
Normalized EBITDA
-27,752
--
-27,683
-20,498
-11,288
12/31/2020 - 11/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers